IMMUTEP LTD-SP ADR (IMMP:NASDAQ)
$0.3141 -0.0071 (-2.2105%)
Analysed IMMUTEP LTD-SP ADR (IMMP:NASDAQ) News Sources
Immutep Reports Progress from Phase I Study of LAG-3 Agonist for Autoimmune Diseases
19-03-2026
yahoo.com
Adobe downgraded, Nio upgraded: Wall Street’s top analyst calls
14-03-2026
yahoo.com
Immutep’s LAG-3 hopes take a hit on Phase III NSCLC termination
13-03-2026
clinicaltrialsarena.com
TACTI-004 Phase III Study in First Line NSCLC to be discontinued following Futility Analysis
13-03-2026
yahoo.com
Evotec, Vistagen lay off staff; Immutep shares collapse on study failure
13-03-2026
biopharmadive.com
3 ASX Penny Stocks With Market Caps Under A$600M
18-02-2026
yahoo.com
Immutep Limited (ASX:IMM) is largely controlled by institutional shareholders who own 50% of the company
09-02-2026
yahoo.com
Immutep Achieves 50% Enrolment in Global TACTI-004 (KEYNOTE-F91) Phase III Trial in 1L NSCLC
06-02-2026
yahoo.com
Immutep Quarterly Activities Report Q2 FY26
29-01-2026
yahoo.com
Dr. Reddy's Laboratories Q3 Earnings Call Highlights
21-01-2026
marketbeat.com
What is the current price of IMMUTEP LTD-SP ADR (IMMP:NASDAQ)?
The current price of IMMUTEP LTD-SP ADR (IMMP:NASDAQ) is $0.3141.
IMMUTEP LTD-SP ADR (IMMP:NASDAQ) absolute price change since previous trading day?
The absolute price change of IMMUTEP LTD-SP ADR (IMMP:NASDAQ) since the previous trading day is $-0.0071.
IMMUTEP LTD-SP ADR (IMMP:NASDAQ) percentage price change since previous trading day?
The percentage price change of IMMUTEP LTD-SP ADR (IMMP:NASDAQ) since the previous trading day is -2.2105%.
What is the most recent average sentiment score for IMMUTEP LTD-SP ADR (IMMP:NASDAQ)?
The most recent average sentiment score for IMMUTEP LTD-SP ADR (IMMP:NASDAQ) is 73 out of 100.
What is the most recent average sentiment for IMMUTEP LTD-SP ADR (IMMP:NASDAQ)?
The most recent sentiment for IMMUTEP LTD-SP ADR (IMMP:NASDAQ) is .
SEC-8K** Filing Available For IMMUTEP LTD-SP ADR (IMMP:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.